![](https://i0.wp.com/lgenia.com/wp-content/uploads/2020/02/IMG_0081-1024x1024.png?resize=1024%2C1024&ssl=1)
At the spring 2018 meeting of the Bill and Melinda Gates Foundation’s TB Drug Accelerator, two new institutions were elected as full member collaborators – Harvard University and LGENIA! We now join 20 other member organizations in this important mission, and we are proud to be the first biotechnology company on their team.